ChengDa Pharmaceuticals Co., Ltd. (SHE:301201)

China flag China · Delayed Price · Currency is CNY
38.30
-0.35 (-0.91%)
At close: Feb 2, 2026
108.15%
Market Cap5.84B +99.3%
Revenue (ttm)374.46M -5.9%
Net Income-51.72M
EPS-0.34
Shares Out151.47M
PE Ration/a
Forward PEn/a
Dividend0.20 (0.52%)
Ex-Dividend DateJul 10, 2025
Volume2,480,203
Average Volume7,182,845
Open38.12
Previous Close38.65
Day's Range38.12 - 39.85
52-Week Range18.00 - 61.11
Beta0.23
RSI37.37
Earnings DateApr 28, 2026

About ChengDa Pharmaceuticals

ChengDa Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates, chemical ingredients, and food and feed additives in China and internationally. It offers process research and development, process optimization, quality and stability research, customized production and other services for pharmaceutical intermediates and APIs; and food and feed additives, such as L-carnitine and L-carnitine tartrate. The company also provides bulk drug products, including urogenital, nervous system, ... [Read more]

Sector Healthcare
Founded 1980
Employees 656
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301201
Full Company Profile

Financial Performance

Financial Statements